B·R·A·H·M·S™ AFP KRYPTOR™
B·R·A·H·M·S™ AFP KRYPTOR™
Thermo Scientific™

B·R·A·H·M·S™ AFP KRYPTOR™

B·R·A·H·M·S provides a complete portfolio of biomarkers for the most reliable results in prenatal screening. Reach high precision for trisomy screening in first and second trimester of pregnancy and neural tube defect screening in second trimester of pregnancy with B·R·A·H·M·S AFP KRYPTOR.
Have Questions?
更改视图buttonViewtableView
货号描述适用于（应用）形式
816075NImmunofluorescent assay for quantitative determination of Alpha-Fetoprotein (AFP)
Aid in risk assessment of fetal trisomy 21 in first trimester of pregnancy, risk assessment of fetal trisomy 21 and 18 in second trimester of pregnancy, an aid to be used in conjunction with clinical evaluation for non-invasive risk assessment of fetal neural tube defects in serum and plasma (herapin) and diagnosis of fetal neural tube defects in amniotic fluid in the second trimester in pregnant women, aid in diagnosis of patients with suspected hepatocellular carcinomas or non-seminomatous germ cell tumors, and in the follow up of patients with confirmed hepatocellular carcinomas or non-seminomatous germ cell tumors.
Lyophilized
081691NCalibrator for B·R·A·H·M·S AFP KRYPTOR (1 level)Readjust the standard curve memorized in B·R·A·H·M·S KRYPTOR compact PLUS/KRYPTOR GOLDReady-to-Use (RTU)
081693NDiluent for B·R·A·H·M·S AFP KRYPTORDilution of samples for AFP measurement on B·R·A·H·M·S KRYPTOR compact PLUS/KRYPTOR GOLDReady-to-Use (RTU)
货号 816075N
价格（CNY)/ 1 kit
-
申请报价
描述:
Immunofluorescent assay for quantitative determination of Alpha-Fetoprotein (AFP)
适用于（应用）:
Aid in risk assessment of fetal trisomy 21 in first trimester of pregnancy, risk assessment of fetal trisomy 21 and 18 in second trimester of pregnancy, an aid to be used in conjunction with clinical evaluation for non-invasive risk assessment of fetal neural tube defects in serum and plasma (herapin) and diagnosis of fetal neural tube defects in amniotic fluid in the second trimester in pregnant women, aid in diagnosis of patients with suspected hepatocellular carcinomas or non-seminomatous germ cell tumors, and in the follow up of patients with confirmed hepatocellular carcinomas or non-seminomatous germ cell tumors.
形式:
Lyophilized

B·R·A·H·M·S provides a complete portfolio of biomarkers for the screening of fetal defects in first and second trimester of pregnancy and biomarkers for diagnosis and monitoring of cancer. B·R·A·H·M·S AFP KRYPTOR is indicated as an aid to be used in conjunction with clinical evaluation to help identify pregnancies at risk of trisomy 21 in first trimester, of trisomy 21 and 18 and neural tube defects in second trimester, and as an aid for the diagnosis and monitoring of patients with hepatocellular carcinomas or non-seminomatous germ cell tumors.

US Only: Product is not 510k cleared in US.

Get confidence in your results with the high precision of B·R·A·H·M·S AFP KRYPTOR and its short incubation time.

  • Save cost and time with a multiparametric control containing 3 parameters: PAPP-A, Free βhCG and AFP
  • Incubation time of only 9 minutes for a short turnaround time
  • Allows measurement in serum, plasma (heparin) and amniotic fluid
  • Large capacity with 75 tests
  • Kit stable up to 15 days after opening onboard the instrument
  • Easy workflow with only 1 calibrator and one calibration every 2 weeks
  • Fits your throughput need with B·R·A·H·M·S KRYPTOR compact PLUS or B·R·A·H·M·S KRYPTOR GOLD
  • Allows risk calculation in first and second trimester with B·R·A·H·M·S Fast screen pre I plus
Thermo Fisher Scientific products are distributed globally and their uses, applications, indications, claims and availability of products in each country depend on local regulatory marketing authorization status, please consult the Instructions For Use (IFU) available in your country.
规格
描述Immunofluorescent assay for quantitative determination of Alpha-Fetoprotein (AFP)
可检测分析物alpha-fetoprotein
检测方法Immunofluorescence
样品类型Serum, plasma (heparin), amniotic fluid
适用于（应用）
Aid in risk assessment of fetal trisomy 21 in first trimester of pregnancy, risk assessment of fetal trisomy 21 and 18 in second trimester of pregnancy, an aid to be used in conjunction with clinical evaluation for non-invasive risk assessment of fetal neural tube defects in serum and plasma (herapin) and diagnosis of fetal neural tube defects in amniotic fluid in the second trimester in pregnant women, aid in diagnosis of patients with suspected hepatocellular carcinomas or non-seminomatous germ cell tumors, and in the follow up of patients with confirmed hepatocellular carcinomas or non-seminomatous germ cell tumors.
包括Kit for 75 determinations
分析时间9 minutes
形式Lyophilized
Unit Size1 kit
内容与储存
Kit for 75 determinations, 2°C to 8°C